GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Diamond Biofund Inc (TPE:6901) » Definitions » COGS-to-Revenue

Diamond Biofund (TPE:6901) COGS-to-Revenue : 0.00 (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Diamond Biofund COGS-to-Revenue?

Diamond Biofund's Cost of Goods Sold for the three months ended in Dec. 2024 was NT$0.00 Mil. Its Revenue for the three months ended in Dec. 2024 was NT$0.00 Mil.

Diamond Biofund's COGS to Revenue for the three months ended in Dec. 2024 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Diamond Biofund's Gross Margin % for the three months ended in Dec. 2024 was N/A%.


Diamond Biofund COGS-to-Revenue Historical Data

The historical data trend for Diamond Biofund's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diamond Biofund COGS-to-Revenue Chart

Diamond Biofund Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
COGS-to-Revenue
Get a 7-Day Free Trial - - - - -

Diamond Biofund Quarterly Data
Dec19 Dec20 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Diamond Biofund COGS-to-Revenue Calculation

Diamond Biofund's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 0
=

Diamond Biofund's COGS to Revenue for the quarter that ended in Dec. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Diamond Biofund  (TPE:6901) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Diamond Biofund's Gross Margin % for the three months ended in Dec. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0 / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Diamond Biofund COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Diamond Biofund's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Diamond Biofund Business Description

Traded in Other Exchanges
N/A
Address
No. 236, Section 4, Xinyi Road,, 11th Floor, Daan District, Taipei City, TWN, 106047
Diamond Biofund Inc is a sustainable biotech venture capital that focuses on the field of biotechnology and medical investment, targeting global and internationally competitive investment targets, including new drug research and development, high-end medical equipment, innovative medical service technology, medical access, agricultural biotechnology.

Diamond Biofund Headlines

No Headlines